World's Best Scientists 2026 revealed!
Lucienne Chatenoud

Lucienne Chatenoud

D-Index & Metrics

Medicine

D-Index
77
Citations
22907
World Ranking
18388
National Ranking
610

Lucienne Chatenoud publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lucienne Chatenoud sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 357 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lucienne Chatenoud D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lucienne Chatenoud sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lucienne Chatenoud is affiliated with Inserm in France and focuses research efforts primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several interconnected subfields including Genetics, Infectious Diseases, Immunology, Oncology, and Endocrinology, Diabetes and Metabolism.

The research topics covered by Chatenoud include:

  • Diabetes and associated disorders
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • COVID-19 Clinical Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research

Chatenoud's recent publications reflect a focus on immunological responses, infectious diseases, and diabetes. Notable papers include:

  • "Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19" (2020), published in Blood
  • "Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling" (2020), published in The Journal of Experimental Medicine
  • "Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes" (2023), published in New England Journal of Medicine
  • "Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept" (2021), published in Transplantation
  • "Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma" (2021), published in Blood

The scientist collaborates frequently with several coauthors, including:

  • Amani Ouedrani
  • Isabelle Staropoli
  • Olivier Schwartz
  • Kevan C. Herold
  • Olivier Hermine

Chatenoud publishes regularly in prominent scientific venues. Frequent publication outlets include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • La Revue de Médecine Interne
  • Diabetologie und Stoffwechsel
  • The Journal of Experimental Medicine

The scientist has also contributed to book publications. One example is the volume entitled "Insights in Immunological Tolerance and Regulation: 2022" published by Frontiers Media in 2023.

Best Publications

  • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Bart Keymeulen;Evy Vandemeulebroucke;Anette G. Ziegler;Chantal Mathieu

  • Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

    Lucienne Chatenoud;Eric Thervet;Jacqueline Primo;Jean-Francois Bach

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.

    Mériam Belghith;Jeffrey A Bluestone;Samia Barriot;Jérôme Mégret

  • CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.

    L Chatenoud;J Primo;J F Bach

  • CD3-specific antibodies: a portal to the treatment of autoimmunity

    Lucienne Chatenoud;Jeffrey A. Bluestone

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

    Yenkel Grinberg-Bleyer;Audrey Baeyens;Sylvaine You;Rima Elhage

  • CD3-specific antibody-induced active tolerance: from bench to bedside

    Lucienne Chatenoud

  • Suppressor T cells--they're back and critical for regulation of autoimmunity!

    Lucienne Chatenoud;Benoît Salomon;Jeffrey A. Bluestone

  • In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids.

    Lucienne Chatenoud;Christiane Ferran;Christophe Legendre;Isabelle Thouard

  • Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

    B Keymeulen;M Walter;Chantal Mathieu;L Kaufman

  • Tolerance to Islet Autoantigens in Type 1 Diabetes

    Jean-François Bach;Lucienne Chatenoud

  • Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].

    L Chatenoud;C Ferran;A Reuter;C Legendre

  • Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation

    Christiane Ferran;Kathleen Sheehan;Michel Dy;Robert Schreiber

  • Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.

    Thomas Hueso;Thomas Hueso;Cécile Pouderoux;Hélène Péré;Anne Lise Beaumont

  • The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties.

    Sarah Bolt;Edward Routledge;Irene Lloyd;Lucienne Chatenoud

  • Autoimmune Diabetes Onset Results From Qualitative Rather Than Quantitative Age-Dependent Changes in Pathogenic T-Cells

    Sylvaine You;Mériam Belghith;Stephen Cobbold;Marie-Alexandra Alyanakian

  • Deficit of suppressor T cells in active multiple sclerosis.

    Marie-Anne Bach;Elizabeth Tournier;Francoise Phan-Dinh-Tuy;Lucienne Chatenoud

  • Cutting Edge: Immunological Consequences and Trafficking of Human Regulatory Macrophages Administered to Renal Transplant Recipients

    James A. Hutchinson;James A. Hutchinson;Paloma Riquelme;Paloma Riquelme;Birgit Sawitzki;Birgit Sawitzki;Stefan Tomiuk;Stefan Tomiuk

  • Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.

    L Chatenoud;M F Baudrihaye;N Chkoff;H Kreis

Frequent Co-Authors

Jean-François Bach
Jean-François Bach Grenoble Alpes University
Henri Kreis
Henri Kreis Necker-Enfants Malades Hospital
Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Herman Waldmann
Herman Waldmann University of Oxford
Laure-Hélène Noël
Laure-Hélène Noël Necker-Enfants Malades Hospital
Michel Dy
Michel Dy Université Paris Cité
Philippe Menasché
Philippe Menasché Université Paris Cité
Michel Pucéat
Michel Pucéat Aix-Marseille University
Gideon Goldstein
Gideon Goldstein Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various online advanced nursing degrees, especially for those interested in specialized healthcare roles. For many, pursuing a easiest fnp program can be a strategic step to quickly advance clinical knowledge while balancing other responsibilities.

Online education also offers programs like the best pmhnp programs online, which provide excellent clinical placement rates, crucial for hands-on experience in psychiatric mental health nursing—a field closely linked to immunological research in neuroimmune interactions.

Cost can be a significant factor when choosing a degree. Many students seek out cheap psych np programs that maintain high educational standards without imposing heavy financial burdens.

Career-wise, earning a Doctor of Nursing Practice (DNP) degree can substantially impact earning potential. Exploring the dnp salary across different states helps prospective students understand the financial benefits tied to their educational investments and choose the best location for practice.

Best Scientists Citing Lucienne Chatenoud

Trending Scientists